AFLAC Incorporated  

(Public, NYSE:AFL)   Watch this stock  
Find more results for AFL
+0.32 (0.51%)
Mar 2 - Close
NYSE real-time data - Disclaimer
Currency in USD
Range 62.02 - 62.67
52 week 54.99 - 66.01
Open 62.19
Vol / Avg. 1.47M/2.07M
Mkt cap 27.33B
P/E 9.63
Div/yield 0.39/2.49
EPS 6.50
Shares 438.90M
Beta 1.57
Inst. own 67%
May 21, 2015
Aflac Inc Financial Analysts Briefing Add to calendar
May 4, 2015
Aflac Inc Annual Shareholders Meeting Add to calendar
Apr 29, 2015
Q1 2015 Aflac Inc Earnings Call Add to calendar
Apr 28, 2015
Q1 2015 Aflac Inc Earnings Release - 4:00PM EDT - Add to calendar
Mar 3, 2015
Aflac Inc at Raymond James Institutional Investors Conference - 8:40AM EST - Add to calendar
Feb 12, 2015
Aflac Inc at Bank of America Merrill Lynch Insurance Conference
Feb 11, 2015
Aflac Inc at Credit Suisse Group Financial Services Forum
Feb 11, 2015
Aflac Inc at Sterne Agee Financial Institutions Investor Conference
Feb 4, 2015
Q4 2014 Aflac Inc Earnings Call
Feb 3, 2015
Q4 2014 Aflac Inc Earnings Release
More events from DailyFinance »    

Key stats and ratios

Q4 (Dec '14) 2014
Net profit margin 12.75% 12.98%
Operating margin 19.50% 19.76%
EBITD margin - 19.76%
Return on average assets 2.28% 2.45%
Return on average equity 15.42% 17.70%
Employees 8,859 -
CDP Score - 87 B


United States - Map
+1-706-3233431 (Phone)
+1-706-3246330 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money
About Company - Wikipedia


Aflac Incorporated (Aflac) is a general business holding company and acts as a management company, overseeing the operations of its subsidiaries by providing management services. Its business is supplemental health and life insurance, through its subsidiary, American Family Life Assurance Company of Columbus, which operates in the United States and as a branch in Japan. Aflac�s insurance business consists of two segments: Aflac Japan and Aflac U.S. Aflac Japan sells voluntary supplemental insurance products, including cancer plans, general medical indemnity plans, medical/sickness riders, care plans, living benefit life plans, ordinary life insurance plans and annuities. Aflac U.S. sells voluntary supplemental insurance products including loss-of-income products and products designed to protect individuals from depletion of assets (hospital indemnity, fixed-benefit dental, vision care, accident, cancer, critical illness/ critical care, and hospital intensive care plans).

Officers and directors

Daniel P. Amos Chairman of the Board, Chief Executive Officer of the Company and Aflac
Age: 64
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Kriss Cloninger III President, Chief Financial Officer, Treasurer, Director; Chief Financial Officer and EVP of Aflac
Age: 66
Bio & Compensation  - Reuters
Masahiko Furutani Deputy President of Aflac Japan
Age: 56
Bio & Compensation  - Reuters
Charles Ditmars Lake II Chairman of Aflac Japan, President of Aflac International
Age: 52
Bio & Compensation  - Reuters
Tohru Tonoike Vice Chairman of Aflac Japan
Age: 63
Bio & Compensation  - Reuters
Hiroshi Yamauchi President and Chief Operating Officer of Aflac Japan
Age: 62
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Kenneth S. Janke Jr. Executive Vice President, Deputy Chief Financial Officer; President of Aflac U.S.
Age: 55
Bio & Compensation  - Reuters
Eric M. Kirsch Executive Vice President, Global Chief Investment Officer of Aflac
Age: 53
Bio & Compensation  - Reuters
Audrey Boone Tillman Executive Vice President - Corporate Services
Age: 49
Bio & Compensation  - Reuters
June P. Howard Senior Vice President - Financial Services, CAO of the Company and the Aflac; Treasurer of Aflac
Age: 47
Bio & Compensation  - Reuters